Please note

Due to the recent spike in Covid-19 cases, we are no longer able to entertain walk-in visits to our headquarters or any of our facilities.

Moflodex IV infusion

Ferron Par Pharmaceuticals

Ingredients in every 250 ml

Moxifloxacin 400 mg

Each package contains

1 bottle of 250 ml

Dosage form

IV infusion

Dosage formIntravenous infusion



W.H.O. classification


A.T.C. Level 1

Anatomical Main group

J - Antiinfectives for systemic use

A.T.C. Level 2

Therapeutic subgroup

J01 - Antibacterials for Systemic Use

A.T.C. Level 3

Pharmacological subgroup

J01M - Quinolone Antibacterials

Available in




CONSULT YOUR DOCTORSafety of this item for use with alcohol has not been established. Please consult your doctor.


NOT RECOMMENDEDThis item should not be used while operating heavy machinery.


NOT RECOMMENDEDThis item is not safe for use during pregnancy.


NOT RECOMMENDEDThis item is not safe for use during lactation.


Moxifloxacin is indicated for the treatment in adults (≥18 years of age) for the following infections, when caused by bacteria susceptible to Moxifloxacin:
Acute exacerbations of chronic Bronchitis
(I p.358; II p.1; III p.2; IV p.1; V p.1496)
Community-acquired pneumonia
(I p.358; II p.1; III p.2; IV p.1; V p.1496)
Acute bacterial sinusitis
(I p.358; II p.1; III p.2; IV p.1; V p.1496)
Skin and soft tissue infections
Skin and soft tissue infections (V p.1497)
Complicated intra-abdominal infections
due to polymicrobial infections in patients who are intolerance to alternative agents; caused by organisms known to be susceptible to Moxifloxacin.
Intravenous moxifloxacin is only for patients that cannot take oral administration or have been clinically proven have to take parenteral administration. Consideration should be given of official guidance on the appropriate use of antibacterial agents. Moxifloxacin may only be used on prescription and under the constant supervision doctor.